12:00 AM
 | 
May 11, 2004
 |  BC Extra  |  Top Story

Arpida raises CHF 51.3M

Infectious disease company Arpida (Basel, Switzerland) raised CHF 51.3 million ($39.4 million) in a series C round co-led by swissfirst and Temasek....

Read the full 91 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >